Zanaflex is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Advanced Rx Pharmacy Of Tennessee, Llc. The primary component is Tizanidine Hydrochloride.
| Product ID | 80425-0090_b4403bd9-d90f-b1d1-e053-2995a90a0437 |
| NDC | 80425-0090 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zanaflex |
| Generic Name | Tizanidine Hcl 4mg |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-03-20 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA210267 |
| Labeler Name | Advanced Rx Pharmacy of Tennessee, LLC |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Active Ingredient Strength | 4 mg/1 |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-03-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10144-594 | Zanaflex | tizanidine hydrochloride |
| 10144-602 | Zanaflex | tizanidine hydrochloride |
| 10144-604 | Zanaflex | tizanidine hydrochloride |
| 10144-606 | Zanaflex | tizanidine hydrochloride |
| 21695-373 | Zanaflex | tizanidine hydrochloride |
| 55289-612 | Zanaflex | tizanidine hydrochloride |
| 70515-594 | Zanaflex | tizanidine hydrochloride |
| 70515-602 | Zanaflex | tizanidine hydrochloride |
| 70515-604 | Zanaflex | tizanidine hydrochloride |
| 70515-606 | Zanaflex | tizanidine hydrochloride |
| 80425-0022 | Zanaflex | Tizanidine HCL |
| 80425-0023 | Zanaflex | Tizanidine HCl 4mg |
| 80425-0024 | Zanaflex | Tizanidine HCl 4mg |
| 80425-0090 | Zanaflex | Tizanidine HCl 4mg |
| 80425-0144 | Zanaflex | Tizanidine 4mg |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZANAFLEX 75186534 2383531 Live/Registered |
COVIS PHARMA B.V. 1996-10-15 |
![]() ZANAFLEX 74400930 1906277 Dead/Cancelled |
ELAN PHARMACEUTICALS, INC. 1993-06-09 |